Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4456521 | 0.83 | TDP1 (0.36) | TDP1ALDH1A1 | |
| SCHEMBL9213672 | 0.79 | TDP1 (0.59) | TDP1SMN1; SMN2SLC22A6FOLH1HDAC2 | |
| SCHEMBL2186782 | 0.77 | TDP1 (0.39) | TDP1SMN1; SMN2SLC22A6SLC6A2SLC6A4 | |
| SCHEMBL2864190 | 0.77 | TDP1 (0.56) | TDP1SMN1; SMN2SLC22A6FOLH1HDAC2 | |
| SCHEMBL5585209 | 0.77 | TDP1 (0.36) | TDP1SLC6A2SLC6A4BLMSLC6A3 | |
| SCHEMBL28390350 | 0.76 | TDP1 (0.54) | TDP1SMN1; SMN2SLC22A6SLC6A2SLC6A4 | |
| SCHEMBL11734818 | 0.76 | TDP1 (0.54) | TDP1SMN1; SMN2SLC22A6SLC6A2SLC6A4 | |
| SCHEMBL17517216 | 0.74 | TDP1 (1.00) | TDP1SMN1; SMN2SLC22A6TSHRFOLH1 | |
| SCHEMBL22151 | 0.74 | TDP1 (1.00) | TDP1SMN1; SMN2SLC22A6TSHRFOLH1 | |
| SCHEMBL16925719 | 0.74 | TDP1 (1.00) | TDP1SMN1; SMN2SLC22A6TSHRFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9279478-A | — | — | None | — | — | JP | disclosed |
| EP-4384148-A1 | ENTERIC-COATED PARTICLES CONTAINING LACTOFERRIN | Univerza V Ljubljani (SI) | 2024-06-19 | — | — | EP | disclosed |
| EP-3630074-B1 | MULTIPARTICULATE ORAL DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL | GRUENENTHAL GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023036981-A1 | ENTERIC-COATED PARTICLES CONTAINING LACTOFERRIN | UNIVERZA V LJUBLJANI (SI) | 2023-03-16 | — | — | WO | disclosed |
| US-10842752-B2 | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol | EVONIK OPERATIONS GMBH (DE) | 2020-11-24 | — | — | US | disclosed |
| US-10639283-B2 | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol | EVONIK OPERATIONS GMBH (DE) | 2020-05-05 | — | — | US | disclosed |
| EP-3630074-A1 | MULTIPARTICULATE ORAL DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL | Grünenthal GmbH (DE) | 2020-04-08 | — | — | EP | disclosed |
| EP-3223797-B1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK OPERATIONS GMBH (DE) | 2020-02-26 | — | — | EP | disclosed |
| US-20180369151-A1 | MULTIPARTICULATE ORAL DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL | Grünenthal GmbH (DE) | 2018-12-27 | — | — | US | disclosed |
| WO-2018219897-A1 | MULTIPARTICULATE ORAL DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL | Grünenthal GmbH (DE) | 2018-12-06 | — | — | WO | disclosed |
| EP-2887926-B1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINED RELEASE CHARACTERISTIC AND WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK ROEHM GMBH (DE) | 2016-08-10 | — | — | EP | disclosed |
| WO-2016083278-A1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK RÖHM GMBH (DE) | 2016-06-02 | — | — | WO | disclosed |
| WO-2015121189-A1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINED RELEASE CHARACTERISTIC AND WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK INDUSTRIES AG (DE) | 2015-08-20 | — | — | WO | disclosed |
| US-20150209298-A1 | GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK INDUSTRIES AG (DE) | 2015-07-30 | — | — | US | disclosed |
| US-20150190348-A1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINED RELEASE CHARACTERISTIC AND WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK INDUSTRIES AG (DE) | 2015-07-09 | — | — | US | disclosed |
| EP-2887926-A1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINED RELEASE CHARACTERISTIC AND WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | Evonik Industries AG (DE) | 2015-07-01 | — | — | EP | disclosed |
| EP-2887925-A1 | GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | Evonik Industries AG (DE) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014032742-A1 | PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINED RELEASE CHARACTERISTIC AND WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK INDUSTRIES AG (DE) | 2014-03-06 | — | — | WO | disclosed |
| WO-2014032741-A1 | GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL | EVONIK INDUSTRIES AG (DE) | 2014-03-06 | — | — | WO | disclosed |
| JP-H09279478-A | TREATING AGENT FOR FIBER | NOF CORP | 1997-10-28 | — | — | JP | disclosed |